Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : For    symbols : NVSEF    save search

Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Published: 2024-04-24 (Crawled : 05:00) - globenewswire.com
NVS | News | $97.28 2.27% 1.21% 3.5M twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
NVSEF | News | $96.0 0.94% 6.88% 52K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

malaria positive treatment for novartis
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Published: 2024-04-23 (Crawled : 18:00) - globenewswire.com
NVSEF | News | $96.0 0.94% 6.88% 52K twitter stocktwits trandingview |
Health Technology
| | O: 1.69% H: 0.02% C: -0.74%
NVS | News | $97.28 2.27% 1.21% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 4.32% H: 0.0% C: 0.0%

lutathera fda first approved tumors for novartis therapy
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVS | News | $97.28 2.27% 1.21% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: -1.46% H: 0.0% C: 0.0%

fabhalta nephropathy for novartis show
Novartis tender offer for MorphoSys AG commences
Published: 2024-04-11 (Crawled : 09:00) - globenewswire.com
NVSEF | News | $96.0 0.94% 6.88% 52K twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.48% C: -0.17%
NVS | News | $97.28 2.27% 1.21% 3.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.32% H: 0.04% C: -0.56%
MOR | News | $18.04 0.45% 0.44% 180K twitter stocktwits trandingview |
Health Technology
| | O: 0.69% H: 0.0% C: -0.39%

for novartis
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M twitter stocktwits trandingview |

AGBA | $2.97 137.6% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.59 75.27% 41.8% 2M twitter stocktwits trandingview |

ZAPP | $4.44 50.2% 33.12% 370K twitter stocktwits trandingview |
n/a

MTC | $2.24 43.59% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.15 40.0% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.045 35.33% 26.23% 870K twitter stocktwits trandingview |

HKIT | $1.33 30.39% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.35 29.81% 23.53% 7.1M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.5 25.0% 21.88% 280K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.